Recruiting and retaining patients for clinical trials is one of the most intractable problems facing clinical research organizations and biopharma companies. CVS thinks that its thousands of retail locations could be the answer. We also look at Food and Drug Administration-approved video games, tracking ... READ MORE >
5 things to know in life sciences: Week of May 24
Over the past year, there has been a simmering dispute between hospitals and pharmaceutical companies over the 340B drug pricing program. This week, the United States Department of Health and Human Services weighed in strongly on the side of the hospitals. We also look at the discussion at the World Trade ... READ MORE >
5 things to know in life sciences: Week of May 17
While COVID-19 does not discriminate in infecting patients, the data actually shows that virus outcomes have disproportionately affected minority communities. Further, despite a focus on improving diversity in trials for the disease, the trials fell short of diversity goals. A new study looks at why and ... READ MORE >
5 things to know in life sciences: Week of May 10
There are a few key milestones in the life cycle of a biopharma: raising your series A, starting your first clinical trial, going public and, for an increasing percent of companies, launching your first drug on your own. But developing a drug and successfully launching it requires different expertise and ... READ MORE >
5 things to know in life sciences: Week of May 3
Public health experts are raising new concerns that achieving herd immunity in the United States looks increasingly unlikely. Although this doesn’t reduce the urgent need to get as many people vaccinated as possible, it does mean that we may need to begin planning for how we will live with COVID-19 as an ... READ MORE >
5 things to know in life sciences: Week of April 26
Getting people vaccinated can be a public health challenge. Getting them to come back for a second dose at the right time can be even more difficult. This week we highlight why people may be skipping their second COVID-19 dose and how challenging getting that second dose can be even for people motivated ... READ MORE >
5 things to know in life sciences: Week of April 19
This week we look at comments from acting Food and Drug Administration commissioner Janet Woodcock on perceptions that the agency is getting tougher on drug companies during the approval process. We also highlight new uses of CRISPR to control gene expression, venture funds focused on life sciences, newly ... READ MORE >
5 things to know in life sciences: Week of April 12
For the past few months, we've shared stories of positive developments in the race for COVID-19 vaccines and vaccinations. This week, we look at the long backstory of the challenges that have haunted the AstraZeneca vaccine efforts and why it is so critical for the world that these issues are resolved. We ... READ MORE >
5 things to know in life sciences: Week of March 29
Each week, we highlight five things you need to know about in the life sciences industry. Here’s the latest. 1. FTC challenges biopharma merger as antitrust scrutiny grows Less than two weeks after the Federal Trade Commission announced it would be taking a more stringent look at mergers in the ... READ MORE >
5 things to know in life sciences: Week of March 22
In this week’s life sciences roundup: the AstraZeneca-Oxford COVID-19 vaccine has faced challenging headwinds in the past week as several European Union countries paused distribution pending additional information from the European Medicines Agency, and as the National Institute of Allergy and Infectious ... READ MORE >